Here’s what you should know.
1. Cardinal Health posted $35.19 billion in year-over-year revenues for 2017, an increase of 6.1 percent.
2. The company’s medical segment specifically increased 18.6 percent year over year in 2017 to post $31.6 billion in revenues.
3. Cardinal also authorized a share repurchasing program of up to $1 billion of the company’s common shares, which will expire Dec. 31, 2020.
4. Zacks analysts believe the growth is somewhat sustainable attaching a ‘B’ rating to the company. The report said, “The company’s stock is suitable for value and momentum investors.”
More articles on supply chain:
UnitedHealth Group eyes 2nd ambulatory acquisition & more — 9 ASC company key notes
6 things to know about IBS
Oregon House passes extended recovery stay bill, allows ASC patients to stay 48 hours
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
